Ashley Harms

Affiliations: 
University of Alabama, Birmingham, Birmingham, AL, United States 
Google:
"Ashley Harms"
Mean distance: 16.35 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schonhoff AM, Harms AS. (2018) Glial GLP1R: A novel neuroprotector? Movement Disorders : Official Journal of the Movement Disorder Society
Williams GP, Schonhoff AM, Jurkuvenaite A, et al. (2018) Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Journal of Neuroinflammation. 15: 244
Harms AS, Delic V, Thome AD, et al. (2017) α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathologica Communications. 5: 85
Harms AS, Thome AD, Yan Z, et al. (2017) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Experimental Neurology
Qin H, Buckley JA, Li X, et al. (2016) Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 5144-59
Volpicelli-Daley LA, Kirik D, Stoyka LE, et al. (2016) How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson disease? Journal of Neurochemistry
Thome AD, Harms AS, Volpicelli-Daley LA, et al. (2016) microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 2383-90
Ponnazhagan R, Harms AS, Thome AD, et al. (2016) The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology
Thome AD, Standaert DG, Harms AS. (2015) Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. Plos One. 10: e0140566
Lewis TB, Glasgow JN, Harms AS, et al. (2014) Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy. Viruses. 6: 3293-310
See more...